Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Janice Maria Walshe"'
Autor:
Richard S. Finn, Hope S. Rugo, Veronique C Dieras, Nadia Harbeck, Seock-Ah Im, Karen A. Gelmon, Janice Maria Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Roland Gauthier, Dongrui Ray Lu, Sindy Kim, Dennis J. Slamon
Publikováno v:
Journal of Clinical Oncology. 40:LBA1003-LBA1003
LBA1003 Background: PAL was the first cyclin-dependent kinase 4/6 (CDK4/6) inhibitor approved for ER+/HER2– ABC based on the randomized, phase 2 PALOMA-1 study. PALOMA-2 is a randomized, double-blind, phase 3 trial in first-line ER+/HER2– ABC tha
Autor:
Maha AlSendi, Calvin Flynn, Muhammad Raheel Khan, Paul Selvadurai, John Crown, Raymond S. McDermott, Janice Maria Walshe, David William Fennelly, Emer O. Hanrahan, Mark Doherty, Michaela Jane Higgins
Publikováno v:
Journal of Clinical Oncology. 40:e24019-e24019
e24019 Background: 11% of Ireland’s population is above the age of 65. This is projected to double to 1.4 million by 2040 corresponding to doubling of cancer cases. Clinical trials often exclude patients (pts) ≥70; therefore, it can be challengin
Publikováno v:
Journal of Clinical Oncology. 29:e336-e339
Publikováno v:
Journal of Clinical Oncology. 32:e20656-e20656
e20656 Background: Alopecia induced by chemotherapy is a distressing side effect. It can have negative effects on patients' self-esteem, body image and adversely influence choice of chemotherapeuti...
Autor:
Janice Maria Walshe, Raymond S. McDermott, Mohd Syahizul Nuhairy Mohd Sharial, Mark Doherty, Min Yuen Teo
Publikováno v:
Journal of Clinical Oncology. 30:e17561-e17561
e17561 Background: Doubling time in non-SCLC tumors has been well studied, but this is less so in SCLC. We aim to study in vivo doubling time in SCLC using modern imaging techniques. Methods: Patients (pts) with SCLC with both diagnostic computed tom